Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation

American Journal of Roentgenology

Volumn 200, Issue 3, 2013, Pages

  Giesbrandt, Kirk J ^a   Bolan, Candice W ^a   Shapiro, Brian P ^a   Edwards, William D ^b   Mergo, Patricia J ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cardiac MRI; Cardiomyopathy; Radiologicpathologic correlation

Indexed keywords

GADOLINIUM;

CARDIOMEGALY; CARDIOVASCULAR MAGNETIC RESONANCE; CELL LOSS; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORONARY ARTERY OBSTRUCTION; DIASTOLIC DYSFUNCTION; HEART DILATATION; HEART HYPERTROPHY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE RELAXATION; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IRON OVERLOAD; IRON OVERLOAD CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC DILATED CARDIOMYOPATHY; MYOCARDIAL DISEASE; MYOCARDIAL HIBERNATION; NON INVASIVE PROCEDURE; NONISCHEMIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; SUDDEN DEATH; TRICUSPID VALVE REGURGITATION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; IMAGE ENHANCEMENT; METHODOLOGY; PATHOLOGY;

CARDIOMYOPATHY, DILATED; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

MLCS; MLOWN;

EID: 84876069974     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.12.9634     Document Type: Review

References (40)

1. Schuster A, Morton G, Chiribiri A, Perera D, Vanoverschelde JL, Nagel E. Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance. J Am Coll Cardiol 2012; 59:359-370
2. Wijns W, Kolh P, Danchin N, et al Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J 2010; 31:2501-2555
3. Tazelaar HD, Edwards WD. Pathology of cardiac transplantation: recipient hearts (chronic heart failure) and donor hearts (acute and chronic rejection). Mayo Clin Proc 1992; 67:685-696
4. Clark LT. Atherogenesis and thrombosis: mechanisms, pathogenesis, and therapeutic implications. Am Heart J 1992; 123:1106-1109
5. Burke AP, Virmani R. Pathophysiology of acute myocardial infarction. Med Clin North Am 2007; 91:553-572
6. Bockeria LA, Gorodkoy AJ, Dorofeev AV, Alshibaya MD; RESTORE Group. Left ventricular geometry reconstruction in ischemic cardiomyopathy patients with predominantly hypokinetic left ventricle. Eur J Cardiothorac Surg 2006; 29(suppl 1):S251-S258
7. Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994; 89:151-163
8. Cummings KW, Bhalla S, Javidan-Nejad C, Bierhals AJ, Gutierrez FR, Woodard PK. A patternbased approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. RadioGraphics 2009; 29:89-103
9. Florian A, Jurcut R, Ginghina C, Bogaert J. Cardiac magnetic resonance imaging in ischemic heart disease: a clinical review. J Med Life 2011; 4:330-345
10. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453
11. Johnstone RI, Greenwood JP, Biglands JD, Plein S, Ridgway JP, Radjenovic A. Assessment of tissue edema in patients with acute myocardial infarction by computer-assisted quantification of triple inversion recovery prepared MRI of the myocardium. Magn Reson Med 2011; 66:564-573
12. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113:1807-1816.
13. O'Donnell DH, Abbara S, Chaithiraphan V, et al. Cardiac MR imaging of nonischemic cardiomyopathies: imaging protocols and spectra of appearances. Radiology 2012; 262:403-422
14. Harris SR, Glockner J, Misselt AJ, Syed IS, Araoz PA. Cardiac MR imaging of nonischemic cardiomyopathies. Magn Reson Imaging Clin N Am 2008; 16:165-183 [vii]
15. Zhang M, Tavora F, Huebner T, Heath J, Burke A. Allograft pathology in patients transplanted for idiopathic dilated cardiomyopathy. Am J Surg Pathol 2012; 36:389-395
16. de Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 2001; 14:299-306
17. Hughes SE, McKenna WJ. New insights into the pathology of inherited cardiomyopathy. Heart 2005; 91:257-264
18. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance. Circulation 2003; 108:54-59
19. O'Hanlon R, Prasad SK, Pennell DJ. Evaluation of nonischemic cardiomyopathies using cardiovascular magnetic resonance. J Nucl Cardiol 2008; 15:400-416
20. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006; 48:1977-1985
21. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 2005; 112:2821-2825
22. Rybicki BA, Iannuzzi MC, Fredrick MM, et al. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164:2085-2091
23. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58:1204-1211
24. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002; 26:762-767
25. Osman F, Foundon A, Leyva P, Pitt M, Murray RG. Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging. Int J Cardiol 2008; 125:e4-e5
26. Roberts WC, McAllister HA Jr., Ferrans VJ, et al. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 1977; 63:86-108
27. Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011; 4:303-309
28. Banba K, Kusano KF, Nakamure K, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4:1292-1299
29. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J 2009; 157:9-21
30. Lagana SM, Parwani AV, Nichols LC. Cardiac sarcoidosis: a pathology-focused review. Arch Pathol Lab Med 2010; 134:1039-1046
31. Kondur AK, Li T, Vaitkevicius P, Afonso L. Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2 and review of the literature. Clin Cardiol 2009; 32:E54-E58
32. Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treat-ment. J Card Fail 2010; 16:888-900
33. Porter JB. Practical management of iron overload. Br J Haematol 2001; 115:239-252
34. Buja LM, Roberts WC. Iron in the heart: etiology and significance. Am J Med 1971; 51:209-221
35. Olson LJ, Edwards WD, McCall JT, Ilstrup DM, Gersh BJ. Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 1987; 10:1239-1243
36. Olson LJ, Edwards WD, Holmes DR Jr., Miller FA Jr., Nordstrom LA, Baldus WP. Endomyocardial biopsy in hemochromatosis: clinicopathologic correlates in six cases. J Am Coll Cardiol 1989; 13:116-120
37. Narula N, Narula J, Dec GW. Endomyocardial biopsy for non-transplant-related disorders. Am J Clin Pathol 2005; 123(suppl):S106-S118
38. Cheong B, Huber S, Muthupillai R, Flamm SD. Evaluation of myocardial iron overload by T2 cardiovascular magnetic resonance imaging. Tex Heart Inst J 2005; 32:448-449
39. Kletzmayr J, Hörl WH. Iron overload and cardiovascular complications in dialysis patients. Nephrol Dial Transplant 2002; 17(suppl 2):25-29
40. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 2005; 75:241-247